Skip to content

Personalized Physical Back Training Program to Improve Physical Functioning in People With Non-specific Low Back Pain

Personalized Physical Back Training Program to Improve Physical Functioning in People With Non-specific Low Back Pain

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06938568
Acronym
LIFDI
Enrollment
180
Registered
2025-04-22
Start date
2025-05-01
Completion date
2027-12-31
Last updated
2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Therapy, Low Back Pain

Keywords

Physical Functioning, Exercise

Brief summary

Personalized medicine and individualized therapeutic approaches are prominent in current research. But are these approaches also effective for treating non-specific low back pain (NSLBP)? NSLBP is one of the most common musculoskeletal issues, which can impair physical well-being, reduce the quality of life, and limit physical functioning. Additionally, it contributes to substantial direct and indirect healthcare costs, such as frequent doctor visits and work absences. Despite NSLBP being a significant burden for both individuals and society, effective alleviation methods remain unclear. The investigators' research project therefore aims to investigate whether personalized therapy, specifically a personalized physical back training program, can effectively address NSLBP. Within the context of NSLBP, the investigators' specific aim is to improve physical functioning as this outcome is considered relevant from all perspectives, including those of patients, clinical professionals, researchers, and guidelines.

Interventions

OTHERPersonalized back exercises

The study intervention is a 12-week personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are selected through a clinical reasoning process, i.e., they are tailored and problem-oriented, based on the results of a clinical assessment. An initial one-on-one training session will take place to familiarize participants with the back training program, corresponding to the first week's session of the 12-week intervention period. During the 12-week intervention period, the training comprises one supervised group session per week, lasting 30 minutes, along with three individual unsupervised sessions, each lasting 10-15 minutes. Our procedures ensures that both participants and instructors are blinded to the group allocation, allowing both groups to train together (e.g., mixed training groups).

OTHERNon-personalized back exercises

The active control intervention is a 12-week non-personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are not selected through a clinical reasoning process, i.e., they are neither tailored nor problem-oriented nor based on the results of a clinical assessment. An initial one-on-one training session will take place to familiarize participants with the back training program, corresponding to the first week's session of the 12-week intervention period. During the 12-week intervention period, the training comprises one supervised group session per week, lasting 30 minutes, along with three individual unsupervised sessions, each lasting 10-15 minutes. Our procedures ensures that both participants and instructors are blinded to the group allocation, allowing both groups to train together (e.g., mixed training groups).

Sponsors

Claudio Perret
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Access to the University Sports of the Lucerne Universities (i.e., students, employees, alumni, subscribers) * NSLBP for at least 6 weeks * Activity limiting NSLBP (at least one activity with a PSFS Score of ≤ 50/100 on a scale from 0 = unable to perform due to NSLBP to 100 = able to perform at the same level as before NSLBP) * Age between 18 and 65 years * Understand the German language * Willing to participate in the study * Written informed consent

Exclusion criteria

* Specific LBP * Red flags associated with any serious pathology or specific LBP, * Being on a waiting list for or less than 12 months post any surgery of the lower back * Pregnancy or given birth within the last 12 months * Diagnosed central neurological disease * Not allowed to exercise * Participant in the feasibility study * Expecting to be absent for more than 2 weeks during the intervention period

Design outcomes

Primary

MeasureTime frameDescription
Self-rated physical functioningBaseline to 12 weeksChange in Patient-Specific Functional Scale (PSFS), most bothersome activity. Range from 0 (unable to perform due to NSLBP) to 100 (able to perform at the same level as before NSLBP)

Secondary

MeasureTime frameDescription
Self-rated physical functioning (RMDQ)Baseline to 4, 8, 12, and 24 weeksChange in Roland Morris Disability Questionnaire (RMDQ). Range from 0 (no disability) to 24 (maximum disability).
Self-rated physical functioningBaseline to 4, 8, and 24 weeksChange in Patient-Specific Functional Scale (PSFS), most bothersome activity. Range from 0 (unable to perform due to NSLBP) to 100 (able to perform at the same level as before NSLBP)
Health-related quality of life (EQ-VAS)Baseline to 4, 8, 12, and 24 weeksChange in EQ Visual Analogue Scale (EQ-VAS). Range from 0 (lowest health-related quality of life) to 100 (highest health-related quality of life).
Health-related quality of life (EQ-5D-5L)Baseline to 4, 8, 12, and 24 weeksChange in 5-Level EuroQoL5D version (EQ-5D-5L). Range from 0 (lowest health-related quality of life) to 1 (highest health-related quality of life).
Pain intensity (NRS)Baseline to 4, 8, 12, and 24 weeksChange in pain intensity (11-point Numeric Rating Scale, NRS). Range from 0 (no pain) to 10 (pain as bad as you can imagine). Recall period: 7 days.
Safety outcomeDuring the 12 week intervention periodNumber of serious adverse events (SAE) and adverse events (AE) that are deemed possibly, probably, or definitely related to the intervention (according to our protocol and ClinO, Art. 63, Switzerland).

Other

MeasureTime frameDescription
Pain interference (PEG)Baseline to 4, 8, 12, and 24 weeksChange in Pain, Enjoyment, and General Activity (PEG) 3-Item Scale. Range from 0 (no pain; does not interfere) to 10 (pain as bad as you can imagine; completely interferes). Recall period: 7 days.
NSLBP-related work productivity lossBaseline to 4, 8, 12, and 24 weeksChange in Work Productivity and Activity Impairment Questionnaire (WPAI). Percentages, with 0%=no work productivity loss.
Participant satisfactionAt 4, 8, 12, and 24 weeksParticipant satisfaction (e.g., 1. I am satisfied with the training program I received. 2. I am satisfied with the result of the training program). 4-point Likert scale (strongly agree, agree, disagree, strongly disagree).
Pain durationBaseline to 4, 8, 12, and 24 weeksChange in pain duration (e.g., average duration of an episode of NSLBP within the last 7 days). In minutes, hours, or days, with 0 = minimum. Recall period: 7 days.
Pain frequencyBaseline to 4, 8, 12, and 24 weeksChange in number of episodes with NSLBP. Numerically, with 0 = minimum. Recall period: 7 days.

Countries

Switzerland

Contacts

Primary ContactClaudio Perret, PhD
claudio.perret@unilu.ch+41419396650
Backup ContactAndrea M Aegerter, PhD
andrea.aegerter@unilu.ch+41412295739

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026